- Home
- PACS vs LIVN Comparison
PACS vs LIVN Comparison
Compare PACS & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACS
- LIVN
- Stock Information
- Founded
- PACS 2013
- LIVN 1987
- Country
- PACS United States
- LIVN United Kingdom
- Employees
- PACS N/A
- LIVN N/A
- Industry
- PACS
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PACS
- LIVN Health Care
- Exchange
- PACS Nasdaq
- LIVN Nasdaq
- Market Cap
- PACS 2.1B
- LIVN 2.1B
- IPO Year
- PACS 2024
- LIVN 1993
- Fundamental
- Price
- PACS $12.22
- LIVN $53.71
- Analyst Decision
- PACS Strong Buy
- LIVN Strong Buy
- Analyst Count
- PACS 5
- LIVN 7
- Target Price
- PACS $31.00
- LIVN $59.71
- AVG Volume (30 Days)
- PACS 821.4K
- LIVN 454.2K
- Earning Date
- PACS 11-06-2025
- LIVN 11-05-2025
- Dividend Yield
- PACS N/A
- LIVN N/A
- EPS Growth
- PACS 82.80
- LIVN N/A
- EPS
- PACS 0.68
- LIVN N/A
- Revenue
- PACS $3,558,953,000.00
- LIVN $1,309,329,000.00
- Revenue This Year
- PACS $28.62
- LIVN $10.10
- Revenue Next Year
- PACS $16.94
- LIVN $7.83
- P/E Ratio
- PACS $18.01
- LIVN N/A
- Revenue Growth
- PACS 205.08
- LIVN 8.23
- 52 Week Low
- PACS $7.50
- LIVN $32.48
- 52 Week High
- PACS $43.92
- LIVN $58.91
- Technical
- Relative Strength Index (RSI)
- PACS 46.39
- LIVN 53.48
- Support Level
- PACS $12.15
- LIVN $50.41
- Resistance Level
- PACS $13.04
- LIVN $53.46
- Average True Range (ATR)
- PACS 0.70
- LIVN 1.32
- MACD
- PACS -0.20
- LIVN 0.16
- Stochastic Oscillator
- PACS 7.64
- LIVN 93.00
About PACS PACS Group Inc. Common Stock
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.